<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01454388</url>
  </required_header>
  <id_info>
    <org_study_id>breakfast colonoscopy study</org_study_id>
    <nct_id>NCT01454388</nct_id>
  </id_info>
  <brief_title>A Trial Comparing Breakfast Versus no Breakfast Prior to Colonoscopy</brief_title>
  <official_title>A Randomized Controlled Trial Comparing Breakfast Versus no Breakfast</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hotel Dieu Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Queen's University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In addition to bowel cleansing agents, the current practice of bowel preparation for&#xD;
      colonoscopy involves a low residue diet 48 hours prior to and a clear fluid diet the day&#xD;
      before the procedure. This study aims to test whether patients who consume a low residue&#xD;
      breakfast the day prior to colonoscopy have a difference in the quality of their bowel&#xD;
      preparation. Patients requiring outpatient colonoscopies will be asked to participate. They&#xD;
      will be randomized to either breakfast or no breakfast the day before the procedure. Colon&#xD;
      cleanliness, patient hunger, and tolerance will be assessed.&#xD;
&#xD;
      The investigators hypothesize that there will be no difference in bowel preparation scores&#xD;
      and will be better tolerated&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Colon cleansing prior to colonoscopy is essential for an adequate examination. Research has&#xD;
      shown that preparation prior to colonoscopy remains one of the biggest deterrents for&#xD;
      patients considering colon screening (1).&#xD;
&#xD;
      In addition to the bowel cleansing agents another important aspect of the preparation is the&#xD;
      diet consumed prior to the procedure. Currently 48 hours prior to colonoscopy patients are&#xD;
      asked to consume a low residue diet. The day before the procedure they are switched to a&#xD;
      clear fluid only diet which many patients find difficult to follow due to hunger and can lead&#xD;
      to non-compliance with the preparation.&#xD;
&#xD;
      There have been no trials to date which have answered the question whether the consumption of&#xD;
      breakfast alters colon cleansing with the cleansing agents currently used in Canada.&#xD;
      Investigators found that in patients receiving sodium phosphate preparations, a full&#xD;
      breakfast or low residue lunch had no effect on colon cleansing scores and improved hunger&#xD;
      and energy levels (2). Several studies have looked at the result of low residue diet kits&#xD;
      taken the day prior to the procedure and showed no difference in colon cleansing or&#xD;
      tolerability compared to the traditional clear fluid regime (3,4).&#xD;
&#xD;
      This study aims to test whether patients who consume a low residue breakfast the day prior to&#xD;
      colonoscopy have a difference in the quality of their colon cleansing or tolerability of the&#xD;
      preparation compared to those who consume a clear fluid diet. The investigators hypothesize&#xD;
      that there will be no difference in bowel preparation scores and will be better tolerated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>bowel cleansing efficacy</measure>
    <time_frame>2 days</time_frame>
    <description>Quality of bowel cleansing as measured by Ottawa Bowel Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hunger</measure>
    <time_frame>day of colonoscopy (day 1)</time_frame>
    <description>Using a tolerance scale and VAS hunger will be assessed</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">496</enrollment>
  <condition>Clinically Indicated Colonoscopy</condition>
  <arm_group>
    <arm_group_label>PEG plus breakfast</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients are allowed to have a low residue breakfast the day prior to colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEG without breakfast</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>picosalax plus breakfast</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients are allowed to have a low residue breakfast the day prior to colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>picosalax without breakfast</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>breakfast</intervention_name>
    <arm_group_label>PEG plus breakfast</arm_group_label>
    <arm_group_label>picosalax plus breakfast</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients for whom a GI physician has ordered a colonoscopy will be approached for&#xD;
             inclusion in the trial&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ileus or bowel obstruction -significant constipation (&lt;3 spontaneous bowel&#xD;
             movements/day)- previous colorectal surgery&#xD;
&#xD;
          -  ascites&#xD;
&#xD;
          -  active inflammatory bowel disease&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  recent (&lt;6 months) myocardial infarction or unstable angina&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence Hookey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hotel Dieu Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 5G2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <study_first_submitted>October 12, 2011</study_first_submitted>
  <study_first_submitted_qc>October 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2011</study_first_posted>
  <last_update_submitted>December 16, 2015</last_update_submitted>
  <last_update_submitted_qc>December 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen's University</investigator_affiliation>
    <investigator_full_name>Dr. Lawrence Hookey</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

